Sercloremine
Sercloremine (CGP-4718A), usually as the hydrochloride salt, is a drug which was developed in the 1980s and was formerly under investigation as an antidepressant, but was never marketed.[1][2] It acts as a selective, reversible inhibitor of monoamine oxidase A (RIMA) and serotonin reuptake inhibitor.[1][3]
![]() | |
Names | |
---|---|
IUPAC name
4-(5-Chloro-1-benzofuran-2-yl)-1-methylpiperidine | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C14H16ClNO |
Molar mass | 249.74 g¡molâ1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Barrie Hesp; Cain (2 September 1987). ANNUAL REPORTS IN MED CHEMISTRY V22 PPR. Academic Press. pp. 25â. ISBN 978-0-08-058366-2.
- C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1801â. ISBN 978-0-412-46630-4.
- Delini-Stula, A.; Fischbach, R.; Gnirss, F.; Bures, E.; PĂśldinger, W. (1985). "Early experience with CGP 4718 A (Sercloremine), a new selective and reversible MAO-A and 5-HT-uptake inhibitor, in the treatment of depressive patients". Drug Development Research. 6 (4): 371â384. doi:10.1002/ddr.430060409. ISSN 0272-4391.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.